Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol

INTRODUCTION: Pre-eclampsia is a common pregnancy condition affecting between 3% and 7% of women. Unfortunately, the exact pathophysiology of the disease is unknown and as such there are no effective treatments that exist notwithstanding prompt delivery of the fetus and culprit placenta. As many cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobson, Sebastian R, Lim, Rebecca, Gardiner, Elizabeth E, Alers, Nicole O, Wallace, Euan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780337/
https://www.ncbi.nlm.nih.gov/pubmed/24056493
http://dx.doi.org/10.1136/bmjopen-2013-003788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780337/
https://www.ncbi.nlm.nih.gov/pubmed/24056493
http://dx.doi.org/10.1136/bmjopen-2013-003788

Ejemplares similares